Senate Finance Dives Deeper Into PBM Weeds, Including Brand Over Generic Preferences

 
• By Sarah Karlin-Smith
  
three-tied cake
The Senate Finance Committee wants PBM justification of brand vs. generic, biosimilar tiering preferences. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legislation

More from Pink Sheet